Home › Funds › AIA Group Ltd › EW
AIA Group Ltd position in EW
EDWARDS LIFESCIENCES CORP · Health Care
AIA Group Ltd reported holding 311,846 shares of EW (EDWARDS LIFESCIENCES CORP) in its Q3 2026 13F filing — a position valued at US$26.9M, representing 0.33% of its reported portfolio and ranking #45 among its reported holdings. AIA Group Ltd has disclosed EW holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How AIA Group Ltd's EW position evolved
AIA Group Ltd first disclosed a stake in EW in Q3 2023 at 467,293 shares (US$32.4M). The position peaked in Q4 2024 at 930,933 shares, worth US$68.9M. Across 13 filings, AIA Group Ltd increased the stake 6 time(s), trimmed it 6 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 311,846 shares valued at US$26.9M — an increase of 99,041 shares quarter over quarter.. Notable position changes include a 92% increase in Q3 2024 (shares rose 12% over the following quarter), a 59% trim in Q4 2025 (shares fell 6% over the following quarter), a 55% increase in Q2 2026 (shares fell 5% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 467.29K | $32.37M | New |
| Q4 2023 | 601.75K | $45.88M | Add |
| Q1 2024 | 492.97K | $47.11M | Reduce |
| Q2 2024 | 390.97K | $36.11M | Reduce |
| Q3 2024 | 749.52K | $49.46M | Add |
| Q4 2024 | 930.93K | $68.92M | Add |
| Q1 2025 | 665.58K | $48.24M | Reduce |
| Q2 2025 | 622.91K | $48.72M | Reduce |
| Q3 2025 | 308.23K | $23.97M | Reduce |
| Q4 2025 | 126.96K | $10.82M | Reduce |
| Q1 2026 | 137.04K | $10.97M | Add |
| Q2 2026 | 212.81K | $19.25M | Add |
| Q3 2026 | 311.85K | $26.92M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About EW and 13F data
EW (EDWARDS LIFESCIENCES CORP) is a Health Care company. 31 other funds we track also report a position in EW — the largest reported positions include Belvedere Trading LLC (US$25.63B), DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt (US$1.18B), Ninety One UK Ltd (US$1.03B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding EW
- Belvedere Trading LLC 3.30M sh · $25.63B · Q3 2026
- DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt 13.00M sh · $1.18B · Q2 2026
- Ninety One UK Ltd 11.94M sh · $1.03B · Q3 2026
- Aristotle Capital Management, LLC 8.67M sh · $783.91M · Q2 2026
- BROWN ADVISORY INC 7.37M sh · $666.33M · Q2 2026
- Artisan Partners Limited Partnership 6.09M sh · $525.69M · Q3 2026
More on AIA Group Ltd
FAQ
How long has AIA Group Ltd held EW?
AIA Group Ltd has disclosed EW holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is AIA Group Ltd's current position in EW?
As of Q3 2026, AIA Group Ltd holds 311.85K shares of EW (EDWARDS LIFESCIENCES CORP), valued at $26.92M, representing 0.33% of its reported portfolio and ranking #45.
Has AIA Group Ltd been buying or selling EW?
In the latest 13F filing (Q3 2026), AIA Group Ltd increased its position in EW. The position peaked in Q4 2024 at 930.93K shares.
Which other funds hold EW?
Other major institutional holders of EW include Belvedere Trading LLC, DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt, Ninety One UK Ltd, among 31 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.